Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01250262 · ClinicalTrials.gov registry record · NA

Resistance Exercise Effects on Fear Avoidance and Physical Function in Obese Older Adults With Low Back Pain

A NA study of Obesity and Low Back Pain, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT01250262: Completed NA study of Obesity and Low Back Pain, sponsored by University of Florida.

NCT01250262 is a NA study of Obesity and Low Back Pain that has completed, run by University of Florida. The registered enrollment target is 72 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01250262, a NA study of Obesity and Low Back Pain, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if a 4 month resistance exercise program reduces the severity of low back pain, pain-related fear avoidance and improves mobility compared to standard care.

Primary Outcome

The VAS scale will range from 0-10 cm, where a rating of "0" reflects no pain, and a "10" rating represents "worst pain imaginable. Subjects will complete the VAS at the indicated time intervals to document any change in their pain levels.

Conditions Studied

Interventions

  • OTHER normal medical care and follow up
  • OTHER Isolated Lumbar Resistance Exercise Program
  • OTHER Total Body Resistance Exercise Program

Study Locations (1)

Florida

  • UF&Shands Orthopaedics and Sports Medicine Institute - Gainesville

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2010-11
Est. Completion 2014-02
Phase NA
University of Florida

1,106 total trials

What the finished NCT01250262 record still lists

NCT01250262 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which normal medical care and follow up is the first listed.

NCT01250262 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT01250262 about?

NCT01250262 is a clinical study titled "Resistance Exercise Effects on Fear Avoidance and Physical Function in Obese Older Adults With Low Back Pain". The purpose of this study is to determine if a 4 month resistance exercise program reduces the severity of low back pain, pain-related fear avoidance and improves mobility compared to standard care.

What is the current status of trial NCT01250262?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2010-11. Estimated completion is 2014-02.

What conditions does trial NCT01250262 study?

This clinical trial studies the following conditions: Obesity, Low Back Pain.

What interventions are being tested in trial NCT01250262?

The interventions under investigation include: normal medical care and follow up (OTHER), Isolated Lumbar Resistance Exercise Program (OTHER), Total Body Resistance Exercise Program (OTHER).

Who is sponsoring clinical trial NCT01250262?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01250262 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01250262's enrollment target sits among peer trials

72 583rd of 1053 higher than 462 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01250262, the US trial registry maintained by the National Library of Medicine. NCT01250262 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.